Company / Operating Cash Flow per Share
Amylyx Pharmaceuticals, Inc. Operating Cash Flow per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow per Share
-$1.12
FY2025
5-year range
-$25.62 / $0.18
FY2021-FY2025
Trend
+54.0%
vs FY2024
Sector context
#119 of 212
Health Care
What the data says
At $-1.12, Amylyx Pharmaceuticals, Inc.'s operating cash flow per share ranks #119 of 212 in the Health Care sector. Operating Cash Flow per Share has fluctuated over the past 5 years, ranging from $-25.62 in FY2022 to $0.18 in FY2023.
Based on SEC 10-K filings.
-1.12 in FY2025.
Declined from $0.18 to $-1.12 over the past 2 years.
Health Care sector context is included.
Operating Cash Flow per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#119 of 212 in Health CareTop 56% of 212This company -$1.12 Sector average -$14.72
▼
+92.4% above sector average
Key checks
Key Insights
- In FY2025, operating cash flow per share increased 54.0% year-over-year.
- Ranks #119 out of 212 companies in the Health Care sector.
- Peak operating cash flow per share was recorded in FY2023.
- Lowest operating cash flow per share in the period was in FY2022.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash Flow per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.12 | +54.0% |
| FY2024 | -$2.44 | -1487.7% |
| FY2023 | $0.18 | +100.7% |
| FY2022 | -$25.62 | -125.6% |
| FY2021 | -$11.36 | - |
As of FY2025 · SEC 10-K · Updated Jul 2, 2026